MoneyWorks4Me

USFDA issues ‘DMF information request’ to SMS Pharmaceuticals

17 Sep 2019 Evaluate

US Food and Drug Administration (USFDA) has issued a ‘DMF information request’ to SMS Pharmaceuticals to provide the information to demonstrate its Ranitidine API manufacturing process does not contain NDMA impurity.

SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..